Foshan Ionova Biotherapeutics Co. Ltd. has discovered new interleukin-17A (IL-17A) inhibitors potentially useful for the treatment of inflammatory disorders.
Foshan Ionova Biotherapeutics Co. Ltd. has discovered new interleukin-17A (IL-17A) inhibitors potentially useful for the treatment of inflammatory disorders.